Data gathered: November 18
AI Stock Analysis - Bristol-Myers Squibb (BMY)
Analysis generated July 21, 2024. Powered by Chat GPT.
Bristol Myers Squibb is a global biopharmaceutical company firmly rooted in a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Headquartered in New York City, the company is well-established in the pharmaceutical industry with a diverse portfolio of products focusing on oncology, immunology, cardiovascular, and fibrotic diseases. The company operates globally and continues to be a major player in the pharmaceutical sector.
Stock Alerts - Bristol-Myers Squibb (BMY)
 |
Bristol-Myers Squibb | November 11 Price is up by 12.2% in the last 24h. |
|
Bristol-Myers Squibb | October 31 Price is up by 6.2% in the last 24h. |
|
Bristol-Myers Squibb | October 7 AI Score is up by 37% in the last couple of days. |
|
Bristol-Myers Squibb | October 4 AI Score is up by 25.7% in the last couple of days. |
Alternative Data for Bristol-Myers Squibb
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $56.80 |
| Target Price | Sign up |
| Volume | 10,500,000 |
| Market Cap | $114B |
| Year Range | $39.03 - $59.82 |
| Dividend Yield | 4.27% |
| PE Ratio | 12.66 |
| Analyst Rating | 35% buy |
| Industry | Drug Manufacturers |
In the news
Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?November 18 - Yahoo Entertainment |
|
 |
Bristol-Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Daiwa AmericaNovember 16 - ETF Daily News |
 |
Bristol-Myers Squibb: Buy This Bargain Before It's GoneNovember 16 - SeekingAlpha |
|
Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $39.00November 16 - ETF Daily News |
 |
Leerink Partnrs Has Bearish Outlook for BMY FY2026 EarningsNovember 15 - ETF Daily News |
Wolfe Research Initiates Coverage of Bristol-Myers Squibb (BMY) with Peer Perform RecommendationNovember 14 - Fintel |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 11.9B | 7.5B | 4.39B | 1.21B | -129M | 1.800 |
| Q2 '24 | 12.2B | 7.67B | 4.53B | 1.68B | -438M | 2.070 |
| Q1 '24 | 11.9B | 7.77B | 4.09B | -11.9B | -8.69B | -4.400 |
| Q4 '23 | 11.5B | 7.19B | 4.29B | 1.76B | 4.29B | 1.590 |
| Q3 '23 | 11B | 6.93B | 4.03B | 1.93B | 4.71B | 2.000 |
Insider Transactions View All
| Holzer Phil M filed to sell 11,760 shares at $55.6. November 5 '24 |
| Hirawat Samit filed to buy 62,109 shares at $54.7. November 5 '24 |
| BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8. December 7 '23 |
| BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9. November 30 '23 |
| Samuels Theodore R. II filed to buy 35,500 shares at $49.8. November 21 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$154.77 0.5% | 51 |
 |
Eli Lilly and CompanyLLY |
$727.2 2.5% | 63 |
 |
PfizerPFE |
$24.86 0.2% | 51 |
 |
AstrazenecaAZN |
$63.39 0.3% | 68 |
 |
AbbVieABBV |
$166.28 0.8% | 59 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $15K - $50K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $15K - $50K |
Read more about Bristol-Myers Squibb (BMY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Bristol-Myers Squibb?
The Market Cap of Bristol-Myers Squibb is $114B.
What is Bristol-Myers Squibb's PE Ratio?
As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.
What is the current stock price of Bristol-Myers Squibb?
Currently, the price of one share of Bristol-Myers Squibb stock is $56.80.
How can I analyze the BMY stock price chart for investment decisions?
The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.
Does BMY offer dividends to its shareholders?
Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 4.27%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bristol-Myers Squibb?
Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.